|
Patient reported medwatch (b)(4) received on 03/15/2024 with health effects of 1876: granuloma and 2360: deformity/disfigurement after artefill/bellafill dermal filler injection.Outcomes attributed to adverse event include: required intervention, other serious or important medical event, and disability or permanent injury.No patient or doctor contact information was provided.
|
|
Patient reported medwatch (b)(4) received on 03/15/2024 with health effects of 1876: granuloma and 2360: deformity/disfigurement after artefill/bellafill dermal filler injection.Outcomes attributed to adverse event include: required intervention, other serious or important medical event, and disability or permanent injury.No patient or doctor contact information was provided.B3: date of event: unknown.D1: brand name: the description of event in (b)(4) includes both bellafill and artefill, which are different brand names for the same product, bellafill being the most recent.D4: additional device information: the bellafill model number is gbf0508.The artefill model number is af0508.Lot numbers were not provided and are unknown.D5: operator of device: the medwatch report did not provide injector information; however, bellafill is sold only to medical professionals.E1: reporter name and address: the patient reported via medwatch.No names, initials, or contact information were provided.E3: occupation: it is suspected that the patient is a non-health professional, but that information is unknown.H6: investigation - medical device problem code: the patient describes bellafill/artefill injections in both "smile lines" and "minuette lines".It cannot be confirmed, but it is suspected that they meant the nasolabial folds and marionette lines, respectively.Marionette lines are off-label for bellafill.No patient or doctor contact information was provided.No artefill or bellafill lot numbers were provided.Suneva medical is unable to proceed with the investigation without additional info.Artefill (now bellafill) dermal filler is indicated for the correction of nasolabial folds and moderate to severe, atrophic, distensible facial acne scars on the cheek in patients over the age of 21 years.Artefill (now bellafill) syringes are single use devices and are typically discarded after use.Per the bellafill ifu: "the syringe and any unused material should be discarded after a single treatment visit.".
|